Developer docs
API playgroundTry for free, no card

Search company profiles

The First Thirty

Full company profile

uuid0008fk2

Namestring
The First Thirty
Legal namestring
The First Thirty
Websiteurl
tft.vc
Company typeenum
Private
Founded yearint
2019
Descriptiontext

The First Thirty (TFT) is a London-based, privately held early-stage venture capital firm investing exclusively in AgriHealth, a category it defines as the deeptech and physical AI companies that measure and verify biological quality from soil to consumer and connect farm-level biology to human healthspan. Its investment thesis is that 40% of arable land is degraded, the food system rewards volume over nutrition, and the emergence of measurable, verifiable biological quality will shift margin and healthcare spend toward prevention; TFT invests in the measurement and verification layer it believes will capture that $12.5 trillion prevention opportunity.

The firm's core product is its AgriHealth Investment Strategy, which invests at pre-seed and seed stages with follow-on capacity at pre-Series A and Series A, primarily in the UK and European Economic Area with opportunistic global reach. The current portfolio of six companies is intentionally assembled as an interconnected value chain: Antler Bio (epigenomic diagnostics for dairy herds), CERVE (digital infrastructure connecting food brands and wholesalers), Edacious (nutrient density intelligence), Mapana AI (field-deployable nutrient sensing), Rhizocore (mycorrhizal fungi library for forestry), and Sifly (autonomous drones for precision agriculture). TFT also operates the Generation-Re community, a co-founded syndicate that has democratised angel investing in regenerative agriculture and produced 30+ community investments.

Revenue is generated through conventional early-stage venture fund economics — management fees on committed capital and carry on successful exits — alongside syndicate and community investment activity. TFT goes to market founder-direct, sourcing pre-seed and seed deals through direct outreach, content marketing via its Insights blog, and field-building through Generation-Re. Customers are limited partners and portfolio founders, not end consumers; pricing (fund terms, carry, management fees) is negotiated privately and not publicly disclosed. The firm had 1-10 employees as of its 2026 strategy launch and is led by Founder and Managing Partner Naeem Lakhani and General Partner Antony Yousefian.

Short descriptiontext

The First Thirty is a London-based early-stage venture capital firm investing in AgriHealth — deeptech and physical AI companies that measure and verify biological quality from soil to consumer, connecting farm-level biology to human healthspan across UK and European markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, agritech investment, early-stage funding, agrifood technology, regenerative agriculture
Industry1 code
1Sustainability & Emissions Analytics for Logistics (CO2e, Fuel, ESG)
CodeTLAEAKAIPrimaryYes
Product category
Venture Capital
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Venture Capital Fund Returns
TypeSubscription Recurring
Description

TFT generates returns through equity investments in early-stage AgriHealth companies. As a venture firm, they likely earn management fees on committed capital and carry on successful fund performance. Their portfolio includes Antler Bio, CERVE, Edacious, Mapana AI, Rhizocore, and Sifly.

tft.vc
2Syndicate and Community Investments
TypeSubscription Recurring
Description

Through track record of syndicate and community investments including Generation-Re community democratizing angel investing in regenerative agriculture and food.

tft.vc
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The First Thirty (TFT) is an early-stage venture capital firm headquartered in London that invests in AgriHealth companies. The firm deploys capital at pre-seed, seed, pre-Series A, and Series A stages into deeptech and physical AI startups that measure and verify biological quality from soil to consumer. Its portfolio includes companies working in epigenomic diagnostics for dairy herds, food supply chain digital infrastructure, nutrient density intelligence, field-deployable nutrient sensing, mycorrhizal fungi libraries, and autonomous agricultural drones.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Achieving preventive health outcomes through agriculture is 100× more cost-effective than conventional healthcare systems
+3 more records
Product overview1 text field

The First Thirty (TFT) is an early-stage venture capital firm specializing in AgriHealth investing. Rather than offering a traditional product, TFT operates as an investment fund that provides capital, strategic support, and operational expertise to early-stage companies building infrastructure for measuring and optimizing biological quality in food systems. TFT's portfolio includes six portfolio companies: Antler Bio (epigenomic diagnostics for dairy herds), Cerve (digital infrastructure connecting food brands and wholesalers), Edacious (nutrient density intelligence), Mapana AI (field-deployable nutrient sensing), Rhizocore (mycorrhizal fungi library for forestry), and Sifly (autonomous drones for precision agriculture).

Product and service1 record
1AgriHealth Investment Strategy
CategoryVenture Capital Fund
Description

An early-stage venture capital fund strategy targeting pre-seed, seed, pre-Series A, and Series A companies in the UK and European Economic Area, focused on AgriHealth deeptech and physical AI startups that measure and verify biological quality from soil to consumer.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Co-founded community democratizing angel investing in regenerative agriculture and food. Part of TFT's field-building strategy with 30+ investments to date through syndicate and community investments.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US venture fund focused on early-stage agrifood-tech companies, particularly those at the intersection of biology, data, and sustainability. Peer to TFT given deeptech orientation and founder-centric early-stage approach.

TypeDirect peer
Description

Amsterdam-based venture capital firm investing globally in early-stage food and agriculture technology. Direct peer to TFT as a specialist agrifood-tech VC targeting transformative founders at the intersection of food, biology, and health.

TypeDirect peer
Description

Global agrifood-tech venture capital firm with a strong portfolio of early- and growth-stage companies. Directly comparable to TFT given its sector-specialist mandate, global deal sourcing, and research-driven thought leadership.

TypeRegional player
Description

Brazilian agrifood-tech venture firm with a Latin America focus and portfolio spanning ag inputs, supply chain, and food tech. Regional peer to TFT in agrifood-tech venture investing.

TypeDirect peer
Description

US-based VC investing across food, agriculture, and ocean technology with a focus on sustainability and health outcomes. Comparable to TFT in its thesis-driven approach to food-system transformation and systems-level portfolio construction.

TypeRegional player
Description

India-focused agritech VC backing early-stage startups transforming Indian agriculture. Regional peer to TFT given comparable stage and agritech focus, though geographically distinct.

TypeDirect peer
Description

Food tech and agritech venture capital firm investing across the alternative protein and food value chain. Peer to TFT for early-stage food-system and bio-based investment focus.

TypeDirect peer
Description

US-based agrifood-tech venture firm with a stage-flexible mandate across the food value chain. Comparable to TFT for sector specialism and focus on supply-chain, food quality, and sustainability.

TypeDirect peer
Description

Berlin-based VC and studio focused on food tech and sustainable food systems across Europe. Direct European peer to TFT in scope, stage, and regenerative/sustainability thesis.

TypeBroad incumbent
Description

Amazon's $2B venture fund investing in sustainable technologies including food, agriculture, and supply chain decarbonization. Broad incumbent peer for TFT given overlap in regenerative agriculture and supply-chain technology investment.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The First Thirty

Venture Capitaltft.vc

The First Thirty is a London-based early-stage venture capital firm investing in AgriHealth — deeptech and physical AI companies that measure and verify biological quality from soil to consumer, connecting farm-level biology to human healthspan across UK and European markets.

What The First Thirty does

The First Thirty (TFT) is a London-based, privately held early-stage venture capital firm investing exclusively in AgriHealth, a category it defines as the deeptech and physical AI companies that measure and verify biological quality from soil to consumer and connect farm-level biology to human healthspan. Its investment thesis is that 40% of arable land is degraded, the food system rewards volume over nutrition, and the emergence of measurable, verifiable biological quality will shift margin and healthcare spend toward prevention; TFT invests in the measurement and verification layer it believes will capture that $12.5 trillion prevention opportunity.

The firm's core product is its AgriHealth Investment Strategy, which invests at pre-seed and seed stages with follow-on capacity at pre-Series A and Series A, primarily in the UK and European Economic Area with opportunistic global reach. The current portfolio of six companies is intentionally assembled as an interconnected value chain: Antler Bio (epigenomic diagnostics for dairy herds), CERVE (digital infrastructure connecting food brands and wholesalers), Edacious (nutrient density intelligence), Mapana AI (field-deployable nutrient sensing), Rhizocore (mycorrhizal fungi library for forestry), and Sifly (autonomous drones for precision agriculture). TFT also operates the Generation-Re community, a co-founded syndicate that has democratised angel investing in regenerative agriculture and produced 30+ community investments.

Revenue is generated through conventional early-stage venture fund economics — management fees on committed capital and carry on successful exits — alongside syndicate and community investment activity. TFT goes to market founder-direct, sourcing pre-seed and seed deals through direct outreach, content marketing via its Insights blog, and field-building through Generation-Re. Customers are limited partners and portfolio founders, not end consumers; pricing (fund terms, carry, management fees) is negotiated privately and not publicly disclosed. The firm had 1-10 employees as of its 2026 strategy launch and is led by Founder and Managing Partner Naeem Lakhani and General Partner Antony Yousefian.

The First Thirty firmographics

Firmographics
Name
The First Thirty
Legal name
The First Thirty
Website
https://tft.vc
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
The First Thirty is a London-based early-stage venture capital firm investing in AgriHealth — deeptech and physical AI companies that measure and verify biological quality from soil to consumer, connecting farm-level biology to human healthspan across UK and European markets.
Ownership category
akta.pro rank

The First Thirty industry classification

Industry
Product category
Venture Capital
akta.pro primary industry
Sustainability & Emissions Analytics for Logistics (CO2e, Fuel, ESG) (TLAEAKAI)

Keywords

  • Venture capital
  • Agritech investment
  • Early-stage funding
  • Agrifood technology
  • Regenerative agriculture

Where The First Thirty is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

The First Thirty business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Venture Capital Fund Returns: TFT generates returns through equity investments in early-stage AgriHealth companies. As a venture firm, they likely earn management fees on committed capital and carry on successful fund performance. Their portfolio includes Antler Bio, CERVE, Edacious, Mapana AI, Rhizocore, and Sifly.
  2. Syndicate and Community Investments: Through track record of syndicate and community investments including Generation-Re community democratizing angel investing in regenerative agriculture and food.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

The First Thirty product offering

Product offering

Core offering

The First Thirty (TFT) is an early-stage venture capital firm headquartered in London that invests in AgriHealth companies. The firm deploys capital at pre-seed, seed, pre-Series A, and Series A stages into deeptech and physical AI startups that measure and verify biological quality from soil to consumer. Its portfolio includes companies working in epigenomic diagnostics for dairy herds, food supply chain digital infrastructure, nutrient density intelligence, field-deployable nutrient sensing, mycorrhizal fungi libraries, and autonomous agricultural drones.

Product overview

The First Thirty (TFT) is an early-stage venture capital firm specializing in AgriHealth investing. Rather than offering a traditional product, TFT operates as an investment fund that provides capital, strategic support, and operational expertise to early-stage companies building infrastructure for measuring and optimizing biological quality in food systems. TFT's portfolio includes six portfolio companies: Antler Bio (epigenomic diagnostics for dairy herds), Cerve (digital infrastructure connecting food brands and wholesalers), Edacious (nutrient density intelligence), Mapana AI (field-deployable nutrient sensing), Rhizocore (mycorrhizal fungi library for forestry), and Sifly (autonomous drones for precision agriculture).

Differentiator

Problem solved

Functional benefit

Products and services

  • AgriHealth Investment Strategy An early-stage venture capital fund strategy targeting pre-seed, seed, pre-Series A, and Series A companies in the UK and European Economic Area, focused on AgriHealth deeptech and physical AI startups that measure and verify biological quality from soil to consumer.

Quantifiable outcome

  • Achieving preventive health outcomes through agriculture is 100× more cost-effective than conventional healthcare systems
  • +3 more outcomes

Companies that use The First Thirty

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles1 record

The First Thirty technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

The First Thirty partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Generation-RecoreStrategic or Co-development Partner · 1 January 2022Co-founded community democratizing angel investing in regenerative agriculture and food. Part of TFT's field-building strategy with 30+ investments to date through syndicate and community investments.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

The First Thirty competitors and assessment

Company assessment

Direct peers

  • Cultivian Sandbox Ventures: US venture fund focused on early-stage agrifood-tech companies, particularly those at the intersection of biology, data, and sustainability. Peer to TFT given deeptech orientation and founder-centric early-stage approach.
  • Anterra Capital: Amsterdam-based venture capital firm investing globally in early-stage food and agriculture technology. Direct peer to TFT as a specialist agrifood-tech VC targeting transformative founders at the intersection of food, biology, and health.
  • AgFunder: Global agrifood-tech venture capital firm with a strong portfolio of early- and growth-stage companies. Directly comparable to TFT given its sector-specialist mandate, global deal sourcing, and research-driven thought leadership.
  • S2G Ventures: US-based VC investing across food, agriculture, and ocean technology with a focus on sustainability and health outcomes. Comparable to TFT in its thesis-driven approach to food-system transformation and systems-level portfolio construction.
  • Synthesis Capital: Food tech and agritech venture capital firm investing across the alternative protein and food value chain. Peer to TFT for early-stage food-system and bio-based investment focus.
  • Lewis & Clark AgriFood: US-based agrifood-tech venture firm with a stage-flexible mandate across the food value chain. Comparable to TFT for sector specialism and focus on supply-chain, food quality, and sustainability.
  • FoodLabs: Berlin-based VC and studio focused on food tech and sustainable food systems across Europe. Direct European peer to TFT in scope, stage, and regenerative/sustainability thesis.

Regional players

  • SP Ventures: Brazilian agrifood-tech venture firm with a Latin America focus and portfolio spanning ag inputs, supply chain, and food tech. Regional peer to TFT in agrifood-tech venture investing.
  • Omnivore: India-focused agritech VC backing early-stage startups transforming Indian agriculture. Regional peer to TFT given comparable stage and agritech focus, though geographically distinct.

Broad incumbents

  • Amazon Climate Pledge Fund: Amazon's $2B venture fund investing in sustainable technologies including food, agriculture, and supply chain decarbonization. Broad incumbent peer for TFT given overlap in regenerative agriculture and supply-chain technology investment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

The First Thirty financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The First Thirty leadership team

Management profile

Number of profiles

Profiles5 records

The First Thirty funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The First Thirty M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The First Thirty

What does The First Thirty do?

The First Thirty (TFT) is an early-stage venture capital firm headquartered in London that invests in AgriHealth companies. The firm deploys capital at pre-seed, seed, pre-Series A, and Series A stages into deeptech and physical AI startups that measure and verify biological quality from soil to consumer. Its portfolio includes companies working in epigenomic diagnostics for dairy herds, food supply chain digital infrastructure, nutrient density intelligence, field-deployable nutrient sensing, mycorrhizal fungi libraries, and autonomous agricultural drones.

Is The First Thirty a public or private company?

The First Thirty is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was The First Thirty founded?

The First Thirty was founded in 2019. It employs 1 to 10 people.

Where is The First Thirty based?

The First Thirty is headquartered in London, United Kingdom, in the Europe region.

How does The First Thirty make money?

Two revenue lines are on record. Venture Capital Fund Returns are the primary driver. The others are syndicate and Community Investments.

Who are The First Thirty's main competitors?

Direct peers on record are Cultivian Sandbox Ventures, Anterra Capital, AgFunder, S2G Ventures, Synthesis Capital, Lewis & Clark AgriFood and FoodLabs. Regional players are SP Ventures and Omnivore. Amazon Climate Pledge Fund is listed as a broad incumbent.

Does The First Thirty have an API?

No public API is recorded for The First Thirty.

What industry is The First Thirty in?

The First Thirty's product category is Venture Capital. Its primary akta.pro industry code is TLAEAKAI, Sustainability & Emissions Analytics for Logistics (CO2e, Fuel, ESG).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AgFunderNews🎥 What is agrihealth—and can it become an investable category? The First Thirty makes the caseAntony Yousefian of The First Thirty argues that falling costs in genomics, sensing, and AI will enable data connections across soil, plants, animals, and human health. He cites Edacious and Cerve as examples, and expects new food giants to emerge, with potential exits via acquisitions like OpenAI's biology purchases.AgnavigatorInvestors should look beyond the farm gate to unlock agri-tech returns, says The First Thirty’s Antony YousefianAntony Yousefian of The First Thirty advocates for an 'agri-health' investment strategy that targets value generation beyond primary farm production to attract venture capital from health-tech and biotech sectors. This approach involves investing in interconnected technologies that create measurable health outcomes, aiming to improve returns by moving away from low-margin primary agriculture.GlobeNewswireBiotech Firm Raises £4.5M for North American ExpansionRhizocore Technologies raised $5.5 million (£4.5 million) to expand into North America, led by The First Thirty. The funding will support U.S. operations and a Scottish facility upgrade, with existing customers having purchased 100% of planned 2025/26 capacity. The company cites a 97% survival rate for treated trees versus 78% for untreated saplings.ScotsmanEdinburgh University spinout secures £4.5 million to grow tree-boosting fungal techRhizocore Technologies, an Edinburgh-based biotech spinout from the University of Edinburgh, has secured £4.5 million in funding to expand its fungal technology that improves tree survival rates. The funding round was led by The First Thirty with participation from Scottish Enterprise, Grosvenor Estate, and other investors, and will support North American expansion and increased production capacity at the company's Scottish facility. The company's ectomycorrhizal fungal technology, drawn from one of the world's largest living fungal libraries, has demonstrated a 97% tree survival rate compared to 78% for untreated saplings.GlobeNewswireBiotech Firm Raises £4.5M for North American ExpansionEdinburgh-based biotech firm Rhizocore Technologies has raised £4.5 million ($5.5 million) in fresh investment to expand into North America, with the funding round led by specialist investor The First Thirty and supported by Scottish Enterprise. The company's flagship product RhizoPellets™ pairs trees with specific ectomycorrhizal fungi to improve survival and growth rates, achieving a 97% survival rate compared to 78% for untreated saplings in trials by Forestry and Land Scotland. The funding will scale U.S. operations to meet demand in a market where over 1.4 billion trees are planted annually, while also upgrading Rhizocore's Scottish facility to fulfill European orders.DIGITScottish Biotech Firm Raises £4.5M for North American ExpansionEdinburgh-based Rhizocore Technologies has raised £4.5 million in investment to scale its fungi-based biotechnology that improves tree survival and growth rates for forestry and woodland restoration. The funding round was led by The First Thirty with participation from Scottish Enterprise, Grosvenor Estate, and other investors, and will fund North American expansion and increased production capacity at the company's Scottish facility. Field trials with Forestry and Land Scotland showed a 97% survival rate for treated saplings versus 78% for untreated ones.